申请人:Ortho Pharmaceutical Corporation
公开号:US05994563A1
公开(公告)日:1999-11-30
Benzyl-phosphonate compounds represented by the formula I: ##STR1## are disclosed as useful in treating bone wasting diseases and as an immunosuppresant.
公式I代表的苄基膦酸酯化合物被披露为治疗骨质疏松症和免疫抑制剂。